TY  - CONF

T1  - Symptomatic skeletal events (SSE) in patients with advanced prostate cancer: Results from a phase III trial of denosumab for the prevention of skeletal-related events.

JO  - Journal of Clinical Oncology

PY  - 2014/05/20

AU  - Klotz L

AU  - Smith MR

AU  - Coleman RE

AU  - Pittman KB

AU  - Milecki P

AU  - Wei R

AU  - Balakumaran A

AU  - Fizazi K

ED  - 

DO  - DOI: 10.1200/jco.2014.32.15_suppl.5075

PB  - American Society of Clinical Oncology (ASCO)

VL  - 32

IS  - 15_suppl

SP  - 5075

EP  - 5075

Y2  - 2025/10/10

ER  -